Article

Nanomedicine Strategies for Management of Drug Resistance in Lung Cancer

2022-01-11

Abstract excerpt

Lung cancer (LC) is one of the leading causes of cancer occurrence and mortality worldwide. Treatment of patients with advanced and metastatic LC presents a significant challenge as malignant cells use different mechanisms to resist chemotherapy. Drug resistance (DR) is a complex process that occurs due to a variety of genetic and acquired factors. Identifying the mechanisms underlying DR in LC patients and possib...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 209fa15f-8972-5172-aa97-ef5d9809a092
DOI: 10.20944/preprints202201.0146.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Nanomedicine Strategies for Management of Drug Resistance in Lung CancerDOI 10.20944/preprints202201.0146.v1Read

Nanomodified strategies to overcome EGFR-tyrosine kinase inhibitors resistance in non-small cell lung cancer.Semantic proximity Read

Modern therapies of nonsmall cell lung cancerSemantic proximity Read

Novel therapeutic approaches for non-small cell lung cancer: an updated view.Semantic proximity Read

Personalized therapy for lung cancer: striking a moving target.Semantic proximity Read

Strategies of overcoming osimertinib resistance in EGFR-mutated non-small cell lung cancer.Semantic proximity Read

Pathological transition as the arising mechanism for drug resistance in lung cancerSemantic proximity Read

Non–Small Cell Lung Cancer Metastatic Without Oncogenic AlterationsSemantic proximity Read

Mechanisms of drugs-resistance in small cell lung cancer: DNA-related, RNA-related, apoptosis-related, drug accumulation and metabolism procedureSemantic proximity Read

Recent progress in drug delivery systems for tyrosine kinase inhibitors in the treatment of lung cancer.Semantic proximity Read

Non-Small Cell Lung Cancer Targeted Therapy: Drugs and Mechanisms of Drug Resistance.Semantic proximity Read

[Research Progress in Immune Checkpoint Inhibitors Combination Therapy Applied to Non-small Cell Lung Cancer after EGFR Mutation-targeted Therapy Resistance].Semantic proximity Read

Cancer drug resistance: A fleet to conquerSemantic proximity Read